ZA796793B - An isoxazole derivative,processes for its preparation,compositions containing it,and its use for combating rheumatism - Google Patents

An isoxazole derivative,processes for its preparation,compositions containing it,and its use for combating rheumatism

Info

Publication number
ZA796793B
ZA796793B ZA00796793A ZA796793A ZA796793B ZA 796793 B ZA796793 B ZA 796793B ZA 00796793 A ZA00796793 A ZA 00796793A ZA 796793 A ZA796793 A ZA 796793A ZA 796793 B ZA796793 B ZA 796793B
Authority
ZA
South Africa
Prior art keywords
rheumatism
combating
processes
preparation
compositions containing
Prior art date
Application number
ZA00796793A
Other languages
English (en)
Inventor
F Kammerer
R Schleyerbach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA796793B publication Critical patent/ZA796793B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
ZA00796793A 1978-12-16 1979-12-14 An isoxazole derivative,processes for its preparation,compositions containing it,and its use for combating rheumatism ZA796793B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782854439 DE2854439A1 (de) 1978-12-16 1978-12-16 Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung

Publications (1)

Publication Number Publication Date
ZA796793B true ZA796793B (en) 1980-11-26

Family

ID=6057414

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00796793A ZA796793B (en) 1978-12-16 1979-12-14 An isoxazole derivative,processes for its preparation,compositions containing it,and its use for combating rheumatism

Country Status (25)

Country Link
US (2) US4284786A (xx)
EP (1) EP0013376B1 (xx)
JP (1) JPS5583767A (xx)
AR (2) AR222680A1 (xx)
AT (1) ATE1067T1 (xx)
AU (1) AU529341B2 (xx)
BG (1) BG60764B2 (xx)
CA (1) CA1129867A (xx)
DE (2) DE2854439A1 (xx)
DK (1) DK149886C (xx)
EG (1) EG13926A (xx)
ES (2) ES486758A1 (xx)
FI (1) FI64154C (xx)
GR (1) GR72731B (xx)
HU (1) HU178015B (xx)
IE (1) IE49126B1 (xx)
IL (1) IL58951A (xx)
LU (1) LU90466I2 (xx)
MX (2) MX6174E (xx)
NL (1) NL990037I1 (xx)
NO (1) NO148925C (xx)
NZ (1) NZ192400A (xx)
PH (1) PH16627A (xx)
PT (1) PT70596A (xx)
ZA (1) ZA796793B (xx)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2538806B1 (fr) * 1982-12-30 1986-02-21 Bago Sa Labor Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US4935434A (en) * 1988-01-26 1990-06-19 Bristol-Myers Company Antiarthritic isoxazole-4-carboxamides
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
FR2662692B1 (fr) * 1990-05-30 1995-04-28 Novapharme Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
BR9008022A (pt) * 1990-05-18 1993-04-06 Hoechst Ag Amida de acido isoxazol-4-carboxilico e amidas de acido hidroxialquilideno-cianoacetico,medicamentos contendo estes compostos e sua aplicacao
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
EP0607777B1 (de) * 1993-01-08 1998-12-09 Hoechst Aktiengesellschaft Verwendung von Leflunomid zur Hemmung von Interleukin 8
ATE174219T1 (de) * 1993-01-08 1998-12-15 Hoechst Ag Verwendung von leflunomid zur hemmung von tumornekrosefaktor alpha
ES2124800T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion de interleuquina 1 beta.
ES2124799T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion de interleuquina 1 alfa.
TW314467B (xx) * 1993-03-31 1997-09-01 Hoechst Ag
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
LT3589B (en) 1993-11-30 1995-12-27 Hoechst Ag Using of known combination for treatment of rejection reaction by transplantation of organs
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
KR100365064B1 (ko) * 1994-10-17 2003-04-11 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 I형알레르기성질환의예방및치료제
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19702988A1 (de) * 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
ES2166205T3 (es) * 1997-08-08 2002-04-01 Aventis Pharma Gmbh Forma cristalina de amida del acido n-(4-trifluorometilfenil)-5-metilisoxazol-4-carboxilico.
US7691890B2 (en) 1998-03-11 2010-04-06 James W. Williams Anti-viral uses of leflunomide products
US20050255071A1 (en) * 1998-12-10 2005-11-17 Aventis Pharma Deutschland Gmbh Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
DE19908527C2 (de) 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
US6566395B1 (en) 1999-05-25 2003-05-20 Biomedicines, Inc. Methods of treating proliferative disorders
DE19960443C2 (de) * 1999-12-15 2002-05-08 Aventis Pharma Gmbh Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen
IL149792A0 (en) * 1999-12-16 2002-11-10 Teva Pharma Novel processes for making and a new crystalline form of leflunomide
EP1257270B1 (en) * 2000-02-15 2005-04-13 Teva Pharmaceutical Industries Ltd. A method for synthesizing leflunomide
EP1473035A1 (en) * 2000-02-15 2004-11-03 Teva Pharmaceutical Industries Ltd. Leflunomide of high purity
WO2002013822A1 (en) * 2000-08-14 2002-02-21 Teva Pharmaceutical Industries Ltd. Micronized leflunomide
EP1381356B1 (en) 2001-04-05 2008-05-28 Aventis Pharmaceuticals Inc. Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
US20030139606A1 (en) * 2001-11-09 2003-07-24 Ray Anup Kumar Process for preparing 5-methylisoxazole-4-carboxylic- (4'-trifluoromethyl)-anilide
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
US20090281106A1 (en) * 2005-08-31 2009-11-12 Kowa Co., Ltd Prophylactic and/or therapeutic method for rheumatoid arthritis
WO2008093246A2 (en) * 2007-02-02 2008-08-07 Vegenics Limited Vegf receptor antagonist for treating organ transplant alloimmunity and arteriosclerosis
CN101817797B (zh) * 2009-02-26 2013-04-10 江苏亚邦爱普森药业有限公司 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US11202853B2 (en) * 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
JP2021519334A (ja) 2018-03-26 2021-08-10 クリア クリーク バイオ， インコーポレイテッド ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法
MX2022010962A (es) 2020-03-06 2022-10-07 Actelion Pharmaceuticals Ltd Metodos para ralentizar la perdida de volumen cerebral.
CA3221343A1 (en) 2021-10-11 2023-04-20 Allitia DIBERNARDO Methods of treating multiple sclerosis
WO2023152290A1 (en) 2022-02-11 2023-08-17 Actelion Pharmaceuticals Ltd Methods of slowing an increase in brain ventricular volume

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087534A (en) * 1974-05-22 1978-05-02 David Ovadia N-haloalkylmio urazole pesticides
DE2524959C2 (de) * 1975-06-05 1983-02-10 Hoechst Ag, 6000 Frankfurt 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel
ES448386A1 (es) * 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten

Also Published As

Publication number Publication date
DK149886B (da) 1986-10-20
DE2854439A1 (de) 1980-07-03
HU178015B (en) 1982-02-28
NO794094L (no) 1980-06-17
ATE1067T1 (de) 1982-06-15
FI64154C (fi) 1983-10-10
DK534279A (da) 1980-06-17
AR222680A1 (es) 1981-06-15
IE792426L (en) 1980-06-16
PT70596A (de) 1980-01-01
US4284786A (en) 1981-08-18
US4351841A (en) 1982-09-28
MX8403A (es) 1994-03-31
EP0013376A3 (en) 1980-09-17
EG13926A (en) 1982-09-30
ES486758A1 (es) 1980-05-16
AU529341B2 (en) 1983-06-02
NZ192400A (en) 1982-02-23
NL990037I2 (nl) 2000-01-03
JPH0133470B2 (xx) 1989-07-13
FI64154B (fi) 1983-06-30
IE49126B1 (en) 1985-08-07
FI793899A (fi) 1980-06-17
IL58951A (en) 1984-01-31
AU5385379A (en) 1980-06-19
CA1129867A (en) 1982-08-17
DK149886C (da) 1987-04-21
JPS5583767A (en) 1980-06-24
AR226894A1 (es) 1982-08-31
BG60764B2 (bg) 1996-02-29
GR72731B (xx) 1983-12-01
MX6174E (es) 1984-12-04
NO148925B (no) 1983-10-03
ES486750A1 (es) 1980-06-16
PH16627A (en) 1983-12-05
IL58951A0 (en) 1980-03-31
LU90466I2 (fr) 2000-01-03
DE2962929D1 (en) 1982-07-08
EP0013376A2 (de) 1980-07-23
NL990037I1 (nl) 2000-01-03
NO148925C (no) 1984-01-11
EP0013376B1 (de) 1982-05-19

Similar Documents

Publication Publication Date Title
ZA796793B (en) An isoxazole derivative,processes for its preparation,compositions containing it,and its use for combating rheumatism
DE2963321D1 (en) 1-benzoyl-2-pyrrolidinone derivative, processes for its preparation and medicaments containing it
GR65650B (en) Derivatives of pyrazolic ethers,method for the preparation thereof and parasiticides containing these compounds
EP0013480A3 (en) Herbicidal pyridinesulfonamides, preparation and use thereof and compositions containing them
PT66076A (en) Process for the preparation of herbicide compounds and compositions
DE2963145D1 (en) Fungicidal acylanilide compounds, their preparation, compositions containing them and their use
PT66150A (en) Process for the preparation of herbicidal compositions
EG13793A (en) Stilbene derivatives,processes for their preparation and their use as insecticides
IL56013A0 (en) Therapeutic compositions containing naphthoquinone derivatives, certain such new compounds and their preparation
ZA796201B (en) Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
IL55315A0 (en) New 4-hydroxy-2-benzimidazolinone derivatives,processes for the preparation thereof and pahrmaceutical compositions containing the same
DE2964930D1 (en) Substituted diphenylamine derivatives, compositions and herbicidal uses thereof, and processes for their preparation
ZA804667B (en) Chemical compositions for treatment of pseudo-folliculitis
DE2962567D1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
IE790231L (en) Compositions suitable for the treatment of heat exhaustion
PT67459A (en) Process for the preparation of thiphosphorylguanidines for combating pests
IL57374A0 (en) 5-arylamino-2,2-difluoro-benzodioxoles, their preparation and their use for combating pests
HU173776B (hu) Gerbicidnyj preparat soderzhahhij tiometil-aril-mochevinu
IL56841A (en) 2-phenyl-5,6-dihydro-4-pyrone derivatives,processes for their preparation and herbicidal compositions containing the same
HU178363B (en) Herbicide compositions containing 2-sulfinyl- or 2-sulfonyl-pyridin-n-oxide derivatives
IL57196A0 (en) -,6-dimesyl-3,4-dimethyl-d-mannitol,its preparation and pharmaceutical compositions containing it
IL50983A0 (en) 5-alkylureido-1,3,4-thiadiazol-2-yl-sulphonyl-acetic-acid derivatives,process for the preparation of said compounds and herbicidal compositions containing the same
IL49858A (en) Herbicidal compositions comprising 3-phenyl-4-piperidinones and 4-di-hydropyridinones,certain such novel compounds and their preparation
AU507473B2 (en) Fungicidal cyclic thiophosphite compositions
IL58806A0 (en) Fungicidal compositions comprising arylhydrazo-aldoximes and derivatives thereof,and certain such new compounds